机械心脏膜血栓形成. 纤维素分解是合理的吗?
R Roudaut1, T Labbe, M F Lorient-Roudaut
1Cardiologic Hospital of Bordeaux, France.
Circulation
|November 1, 1992
概括
纤维溶解疗法为假心血栓形成提供了一个非手术的选择,但它带有诸如脑栓塞等风险. 应仔细考虑其使用,特别是在重症患者中.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 假心血栓是置换手术的重要并发症.
- 管理这种情况可能是具有挑战性的.
- 血栓溶解药物治疗已经成为一种潜在的治疗策略.
研究的目的:
- 评估纤维溶解剂在治疗假心血栓的疗效和安全性.
- 为了比较不同门类型和患者状况的纤维溶解疗法的结果.
主要方法:
- 一项涉及64名患有75例假心血栓瘤的患者的研究.
- 使用纤维溶解剂进行的治疗:链酶,尿酶或复合组织类型等离子体激活剂.
- 收集关于治疗成功,并发症和患者结果的数据.
主要成果:
- 纤维溶解治疗在73%的病例中取得了完全成功,大动脉假肢 (85%) 的结果比 mitrale (63%) 更好.
- 14.6%的患者在治疗期间经历了栓塞,包括四次致命的大脑栓塞.
- 9名患者死亡,18例患者最终需要紧急手术.
结论:
- 纤维溶解药物治疗是一种可行的非手术替代方案,用于假心血栓,特别是在三管病例或重症患者.
- 脑栓塞的风险需要仔细选择患者.
- 需要进一步的研究,以纤维溶解剂来管理副脉栓塞.
相关概念视频
Detergent Purification of Membrane Proteins
Detergents are used to purify the integral proteins of the membrane. The hydrophobic portion of the detergent can replace membrane phospholipids while solubilizing the membrane proteins. When detergent monomers reach a specific concentration in a solution called critical micelle concentration (CMC), they form micelles. Above CMC, the concentration of the detergent monomers remains in equilibrium with the micelle. The number of detergent monomers present in the CMC varies for each detergent, and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...


